Comparative antidiabetic efficacy of Murraya koenigii extract and myricetin-derived copper nanoparticles
DARU Journal of Pharmaceutical Sciences · 29.10.2026 · 34 (2)
DOI: 10.1007/s40199-026-00684-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 29.10.2026. Verfasst von Karishma Waghmare und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Parul University, Vadodara, Gujarat, 391760, India. karishmawaghmare8107@gmail.com. Hauptthemen laut MEDLINE: Murraya, Flavonoids, Hypoglycemic Agents, Diabetes Mellitus, Experimental. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Green synthesis of copper-containing nanoparticles (CuNPs) using plant-derived bioactive compounds is a promising approach for developing potential antidiabetic nanotherapeutics. However, the influence of purified phytochemicals, compared with crude plant extracts, on nanoparticle characteristics and antidiabetic efficacy requires further investigation.
Objective
This study aimed to compare the physicochemical characteristics and antidiabetic efficacy of CuNPs synthesized using Murraya koenigii leaf extract and its isolated flavonoid, myricetin.
Methods
Myricetin was isolated from M. Koenigii and identified and quantified using high-performance thin-layer chromatography (HPTLC), with UV–Visible spectrophotometry used for further characterization. The synthesized cunps were characterized using UV–Visible spectroscopy, X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential analysis, and energy-dispersive X-ray spectroscopy (EDS). Antidiabetic efficacy was evaluated in streptozotocin-induced diabetic male Wistar rats over 21 days.
Results
SEM analysis revealed apparent particle or agglomerate dimensions of 100–450 nm for M. Koenigii -derived cunps, whereas TEM showed predominantly spherical myricetin-derived CuNPs with dimensions of 22–51 nm. DLS analysis showed a hydrodynamic diameter of 237.0 nm and a polydispersity index (PDI) of 0.375 for myricetin-derived cunps, compared with a PDI of 0.454 for M. Koenigii -derived CuNPs. Myricetin-derived CuNPs exhibited a zeta potential of − 26.9 mv. After 21 days of treatment, the mean blood glucose level in the myricetin-derived CuNPs group decreased to 90.25 ± 6.88 mg/dl, compared with 110.68 mg/dl in the free-myricetin group, 119.25 mg/dl in the M. Koenigii -derived CuNPs group, 125.25 mg/dl in the M. Koenigii extract group, and 103.68 mg/dl in the glibenclamide-treated group.
Conclusion
Myricetin-derived CuNPs demonstrated promising antidiabetic activity in streptozotocin-induced diabetic rats and exhibited a comparatively narrower particle-size distribution than M. Koenigii -derived CuNPs. These findings support further investigation of phytochemical-guided CuNPs synthesis for potential antidiabetic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Parul University, Vadodara, Gujarat, 391760, India. karishmawaghmare8107@gmail.com.
- Department of Pharmacognosy, Parul Institute of Pharmacy and Research, Parul University, Vadodara, 391760, India.
Zitieren
APA
Waghmare, K., & Chakraborthy, G. S. (2026). Comparative antidiabetic efficacy of Murraya koenigii extract and myricetin-derived copper nanoparticles. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00684-0
Vancouver
Waghmare K, Chakraborthy GS. Comparative antidiabetic efficacy of Murraya koenigii extract and myricetin-derived copper nanoparticles. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00684-0
BibTeX
@article{Waghmare2026,
author = {Waghmare, Karishma and Chakraborthy, Guno Sindhu},
title = {Comparative antidiabetic efficacy of Murraya koenigii extract and myricetin-derived copper nanoparticles},
journal = {DARU Journal of Pharmaceutical Sciences},
year = {2026},
volume = {34},
number = {2},
doi = {10.1007/s40199-026-00684-0}
}
EUVIMED